Category: Corona Virus Vaccine

Page 50«..1020..49505152..6070..»

New COVID vaccines are here: Now’s the time to get one, officials say – Los Angeles Times

October 29, 2023

With Halloween just days away, and the wider autumn and winter holiday season fast approaching, now is the time for most everyone to get their updated COVID-19 vaccine, officials say especially since initial supply shortages have eased.

There are some indications the winter respiratory virus season is just beginning, exacerbating the threat not only of another potential coronavirus wave, but a resurgence of flu and respiratory syncytial virus, or RSV. Last year, all three viruses surged roughly simultaneously, leaving hospitals straining under the weight of a so-called tripledemic.

We have a good supply of COVID-19 and flu vaccines in Los Angeles County and there are options for everyone 6 months and older, county Public Health Director Barbara Ferrer said in a statement. I hope that if many people take advantage of the updated vaccines, L.A. County can avoid a big surge in respiratory virus cases this winter that strains our healthcare system and leads to more deaths.

So far, though, uptake of the updated shots has not been up to snuff for public health officials.

Only 5% of Californians, or 1.8 million people, have received the updated COVID-19 vaccine since it became available last month. Among seniors, the rate is 14%.

Thats not good enough. We should really be seeing much higher rates, especially amongst the old, Dr. Toms Aragn, director of the California Department of Public Health, said at a briefing Thursday. Winter is coming.

Getting the updated shot now, health officials say, will help protect people against the expected wave of COVID-19 thats historically arrived in November and December.

Federal survey data suggest that 7% of U.S. adults got the new COVID-19 vaccine in the first month of the rollout. In a survey in August, 43% of U.S. adults said they planned to get the latest COVID-19 vaccine, according to findings shared by the U.S. Centers for Disease Control and Prevention.

Such uptake would be more in line with that of the annual flu shot. Survey results suggest 47% of U.S. adults got vaccinated during the 202223 flu season. By contrast, only 21% of adults nationwide received the previously updated COVID-19 shot after it was introduced a year ago.

Separately, a survey of more than 1,000 L.A. County adults by the USC Pandemic Research Center suggested that 64% planned on getting the updated COVID-19 vaccine. That would be significantly higher than the 20% of county residents 5 and older and 41% of seniors countywide who received last years reformulated COVID-19 vaccine.

While state officials are pushing for more residents to get vaccinated, the L.A. City Council on Wednesday introduced a motion to sunset that requirement for city employees. If enacted, it would align with similar outside policies, including in L.A. County and the federal government. The state of California ended coronavirus test requirements for unvaccinated state employees in 2022.

There remain demographic disparities among those who are getting vaccinated. Nearly 9% of those living in Californias wealthiest communities have received the new COVID vaccine, compared with fewer than 2% of those living in the lowest-income areas.

Roughly 7% of white Californians have gotten the vaccine, as have 6% of Asian Americans, 4% of Native Hawaiian/Pacific Islanders, 3% of Black, Native American and multiracial Californians and 1.5% of Latino residents.

If youre 6 months or older, you should be getting vaccinated against COVID-19, regardless of previous immunizations, Aragn said. Its no longer a booster. This is now just one shot. And if its been at least two months since the last time you may have received the old bivalent ... booster, or at least three months since youve recovered from an infection, all you need is one shot.

There are a couple of exceptions. The youngest children and those who are immunocompromised may need more than one dose. That is also the case for previously unvaccinated people choosing to get the Novavax vaccine for their first COVID inoculation.

Vaccine supply shortages have eased in recent weeks. But Kaiser Permanente members in Southern California in particular have reported major problems, including being unable for weeks to find appointments close to their homes.

In a statement Thursday, Kaiser said it has a stable supply of the Pfizer-BioNTech vaccine for all age groups.

All healthcare providers nationwide have experienced supply and shipment challenges during the initial launch of the updated COVID-19 vaccine. The majority of those issues have been resolved, the statement said.

Kaiser said some of its locations do not require appointments and that appointments are being added as needed.

The L.A. County Department of Public Health has said anyone including Kaiser members can get the COVID-19 vaccine at no cost at their vaccine sites, including Ted Watkins Memorial Park in Florence-Firestone and Eugene A. Obregon Park in East L.A., which are open from 11 a.m. to 6 p.m. Wednesday through Sunday.

The county also offers vaccinations at eight public health centers in downtown L.A., Hollywood, Willowbrook, Monrovia, Pacoima, Pomona, Whittier and Lancaster.

The county Department of Public Health is considered in-network for all insurers, and can bill Kaiser for the vaccinations.

Uninsured children can get COVID vaccines for free through the Vaccines for Children program. Uninsured adults can get access to free vaccines through Bridge Access Program sites, which include federally qualified health centers and CVS and Walgreens.

No-cost COVID-19 vaccines are also available at the Orange County Health Care AgencysFamily Health Clinic in Santa Ana.

For now, coronavirus levels in wastewater continue to trend downward in Los Angeles County. For the week that ended Oct. 14, the most recent available, the coronavirus level in sewage was 12% of last winters peak, down from 14% the previous week.

This late-year respiratory virus season is the first since the official end of the COVID-19 emergency. And as many return to pre-pandemic norms such as large indoor family gatherings, Aragn urged residents to get vaccinated not only against COVID-19, but the flu and, for those who are recommended, RSV.

As with COVID, officials recommend everyone 6 months and older get vaccinated against the flu via either a shot or a nasal spray. October is an ideal time to get the flu vaccine, but getting it later in the season can still be helpful. Older people also are eligible for a high-potency version of the flu vaccine.

One new development for the flu vaccine this year is that people with a history of allergy to eggs no longer need to take additional safety precautions, according to the CDC.

Most flu vaccines contain a small amount of egg proteins, such as ovalbumin. However, studies that have examined the use of both the nasal spray vaccine and flu shots in egg-allergic and non-egg-allergic patients indicate that severe allergic reactions in people with egg allergies are unlikely, the CDC said.

People who have allergies to other ingredients in the flu vaccine should still avoid getting vaccinated, the CDC said.

Though flu and COVID-19 are not yet spreading widely, circulation of RSV is starting to pick up, Aragn said. RSV can be dangerous, especially for infants and older adults. Immunizations are available at least for certain people.

Those who are at least 60 should talk with their doctor about getting an RSV vaccine, officials say. There are two brands of RSV vaccines available for this age group, one made by GSK, known as Arexvy;and Abrysvo, made by Pfizer.

Those that have chronic medical conditions are the ones that are at highest risk, Aragn said. However, if youre otherwise a very, very healthy 60-year-old, 65-year-old, in consultation with your doctor, you may decide that youre not going to get the vaccine for RSV.

Those who are pregnant can also get a RSV vaccine. They should get it during September through January, only when they are weeks 32 and 36 of their term, to reduce the risk of severe disease in their infants, as the baby will receive protection that will last for months after birth.

Another option to protect newborns is to give them, after birth, an immunization that has preventive antibodies that helps fight RSV infections and protects them from getting very sick.

The immunization is suggested for infants 8 months and younger, as well as those age 8 to 19 months who are at higher risk of severe illness. These antibodies known by the generic name nirsevimab and the trademarked name Beyfortus, which was developed by AstraZeneca and Sanofi are recommended between September and January to help protect babies during RSV season.

There is a shortage of the nirsevimab immunization, the CDC said this week, particularly for prefilled syringe doses intended for babies weighing 11 or more pounds. The CDC recommended that for babies in that weight range, only those at highest risk for severe RSV disease get the immunization.

Masking up continues to be an important tool to help prevent the transmission of infectious diseases, Aragn added, as well as opening the windows, choosing to eat outdoors, being in spaces that are well ventilated, making sure that you wash your hands, and of course, staying home when youre sick, and making sure that you get tested.

Free coronavirus tests remain available at libraries run by the city and the county of Los Angeles, vaccination sites run by the county Department of Public Health, and many food banks and senior centers. Households are also eligible to order four free at-home tests through covid.gov/tests.

In California, most private insurance plans regulated by the state must reimburse their members for eight at-home COVID test kits a month through Nov. 11. After that date, free COVID tests must still be provided through most insurance plans, but covered people must go through an in-network provider to get them at no cost.

For a number of Medicare patients in California, free COVID-19 at-home tests ended on May 11, but COVID-19 testing remains free if ordered by a doctor. For people with a Medicare Advantage plan, the cost of at-home test kits varies and might remain free in some plans, according to the California Department of Public Health.

The L.A. County Department of Public Health suggested that people test for the coronavirus ahead of indoor Halloween and other holiday activities if the guest list includes people at higher risk, such as grandparents, infants and those who are pregnant.

People who get COVID-19 or flu should ask their healthcare provider about treatment options, such as Paxlovid for COVID or a number of anti-flu drugs.

Read the original post:

New COVID vaccines are here: Now's the time to get one, officials say - Los Angeles Times

Could a New Vaccine Head Off the Next Pandemic? – Yale School of Medicine

October 29, 2023

A new experimental vaccine that could provide protection against multiple varieties of dangerous coronaviruses just passed a major hurdle in its development that may bring it closer to being tested in clinical trials, according to David Martinez, PhD, assistant professor of immunobiology at Yale School of Medicine and a member of the Yale Center for Infection and Immunity.

Coronaviruses are behind some of the deadliest outbreaks of the past few decades. These viruses tend to jump from animal hosts to humans. This has occurred at least three times with different coronaviruses during this century. These viruses then produce deadly respiratory illnesses.

For these reasons, developing vaccines that can provide broad coverage against lethal coronaviruses is essential. In a study published in Cell Reports, Martinez and colleagues at the Duke Human Vaccine Institutewhere Martinez worked before coming to Yale in May 2023tested a newly developed vaccine intended to protect against three deadly coronaviruses, including SARS-CoV-2, the virus that led to the COVID-19 pandemic. Martinez, the studys first and lead corresponding author, led the research team along with co-corresponding authors Ralph Baric, PhD, of the University of North Carolina; and Barton Haynes, MD, and Kevin Saunders, PhD, of Duke University.

The study found that vaccinated mice infected with lethal SARS-CoV 2003 and MERS-CoV survived their infections, while unvaccinated mice did not. The vaccine also provided protection against rising SARS-CoV-2 variants, like XBB1.5. This finding could help move the vaccine into phase-1 clinical trials, says Martinez, andeventuallyinto peoples arms.

While the year 2020 is inextricably linked with the coronavirus dubbed SARS-CoV-2, that virus is just one of many that can cause illness and death. This massive group of viruseswhich can be found in animals all over the worldhad shown itself to be a potential danger to people nearly two decades earlier.

In 2003, a coronavirus called SARS-CoV-1, commonly known as SARS (for severe acute respiratory syndrome), started infecting people in Asia. Presumed to have jumped to people from bats, it infected around 8,000 people, nearly 800 of whom diedmaking SARS-CoV-1 the first new, highly-infectious disease of the 21 st century, according to the World Health Organization. Ten years later, anothertotally distinctcoronavirus called Middle East Respiratory Syndrome (or MERS) also emerged, this time spilling over into people from camels.

Despite their being genetically distinct from one another, the viruses had a few commonalities: each one came from animal hosts, mortality rates were relatively high, and the diseases manifested as respiratory illnesses.

It became very clear that coronaviruses are a public threat to humanity, says Martinez. And then came a virus that needs no introductionSARS-CoV-2.

Martinez started working on a universal coronavirus vaccine during his postdoctoral training at the height of the COVID-19 pandemic. After first focusing his research on the development of a vaccine for SARS-CoV-2 he got caught up in the idea of developing a vaccine that could provide broader coverage for other animal-origin coronaviruses.

The concept has precedent. Other scientists have tried to develop universal vaccines for HIV and viruses that cause influenzawith mixed success. To do this, Martinez and his colleagues searched for an Achilles heelan element that the viruses needed to survive, and that the immune system could be reliably expected to spot. The team chose the RBD receptor, a binding domain found both on MERS and SARS that the viruses need to infect host cells.

To make their vaccine, the researchers engineered a scaffold to attach all three versions of the RBD receptor. They then mixed up the vaccine and injected it into their mice, before introducing their subjects to the three deadly viruses.

Vaccinated mice all survived. But some of the unvaccinated succumbed to their infectionshinting that the vaccine was key to helping mice fend off the worst of the illness.

Previous studiesincluding in labs where Martinez has workedhave tested universal vaccines before. But this study is the first to show that a SARS and MERS vaccine can provide protection against three lethal respiratory illnesses in animals, says Martinez.

The vaccine is a triple threat to the viruses, he says.

The vaccine may work because it reduces viral load in the respiratory and nasal passages. One of the reasons that SARS-CoV-2 and other coronaviruses are thought to be so deadly is that the virus accumulates in cells in the lungs.

The researchers found that vaccinated mice had lower viral load in their upper airway in the respiratory system than unvaccinated micehinting that the vaccine was helping to keep down the viral count and potentially reduce transmission.

And the vaccine wasnt just broadly protective of original variants of SARS-CoV-2. Vaccinated mice also had greater immunity to new COVID variants like XBB1.5, which are being included in the updated versions of the fall COVID booster shots.

The universal coronavirus vaccine wont be available anytime soon. And even if it were, it wouldnt entirely eliminate the need for boosters, says Martinez, who is continuing his work on universal vaccines at Yale. But if it passes clinical trials, it might lengthen the time needed between boosters, he says, as newer variants would have less of an edge than they do now.

The vaccine may be good news for more just than tackling coronaviruses. If a universal coronavirus vaccine is approved, it could open the door for developing other universal vaccines to tackle tricky or deadly illnesses, including influenza, Martinez says.

More:

Could a New Vaccine Head Off the Next Pandemic? - Yale School of Medicine

Protect yourself from COVID-19, flu and RSV Welcome to San … – San Bernardino County (.gov)

October 29, 2023

Aging and Adult Services

Agriculture/Weights & Measures

Airports

Animal Care

Arrowhead Regional Medical Center

Assessor-Recorder-County Clerk

Auditor-Controller/Treasurer/Tax Collector

Behavioral Health

Big Bear Alpine Zoo

Board of Supervisors

Census

Child Support Services

Children and Family Services

Children's Fund

Children's Network

Clerk of the Board

Coalition Against Sexual Exploitation

Code Enforcement

Community Development and Housing

Community Vital Signs

County Administrative Office

County Fire

County Library

County Museum

County Surveyor

Countywide Plan

CountyWire

Disasters

District Attorney

Economic Development Agency

Environment

Environmental Health Services

Equal Opportunity Commission

Facilities Management

First 5 San Bernardino

Fleet Management

Government Works

Grand Jury

Homeownership Protection Program JPA

Housing Authority

Human Resources

Human Services

Innovation and Technology Department

Land Use Services

Office of Emergency Services

Office of Homeless Services

Photos

Preschool Services

Probation Department

Public Defender

Public Health

Public Works

Purchasing Department

Real Estate Services

Redistricting Commission

Regional Parks

Registrar of Voters

San Bernardino County Employees' Retirement Association

SANBAG

SBCERA

Sheriff's Department

South Coast AIr Quality Management District

Special Districts Department

State Legislation Veto

Superintendent of Schools

Superior Court

Transitional Assistance Department

Uncategorized

Veterans Affairs

Videos

Workforce Development Board

Workforce Investment Board

See the article here:

Protect yourself from COVID-19, flu and RSV Welcome to San ... - San Bernardino County (.gov)

Implications of COVID-19 in Acute Mesenteric Ischemia and Bowel … – Cureus

October 29, 2023

Specialty

Please choose I'm not a medical professional. Allergy and Immunology Anatomy Anesthesiology Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and Public Health Family Medicine Forensic Medicine Gastroenterology General Practice Genetics Geriatrics Health Policy Hematology HIV/AIDS Hospital-based Medicine I'm not a medical professional. Infectious Disease Integrative/Complementary Medicine Internal Medicine Internal Medicine-Pediatrics Medical Education and Simulation Medical Physics Medical Student Nephrology Neurological Surgery Neurology Nuclear Medicine Nutrition Obstetrics and Gynecology Occupational Health Oncology Ophthalmology Optometry Oral Medicine Orthopaedics Osteopathic Medicine Otolaryngology Pain Management Palliative Care Pathology Pediatrics Pediatric Surgery Physical Medicine and Rehabilitation Plastic Surgery Podiatry Preventive Medicine Psychiatry Psychology Pulmonology Radiation Oncology Radiology Rheumatology Substance Use and Addiction Surgery Therapeutics Trauma Urology Miscellaneous

Original post:

Implications of COVID-19 in Acute Mesenteric Ischemia and Bowel ... - Cureus

From education to politics: a pan-European analysis of COVID-19 … – News-Medical.Net

October 29, 2023

The rapid outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to a pandemic known as the coronavirus disease 2019 (COVID-19) pandemic.

A recentScientific Reportsstudy assessed the effect of religiosity, education, trust in scientists, and political orientation on peoples belief in COVID-19-related conspiracy theories (CTs) In Europe.

Study:Exploring COVID-19 conspiracy theories: education, religiosity, trust in scientists, and political orientation in 26 European countries. Image Credit:Liftwood/Shutterstock.com

Although CT is omnipresent, its prevalence in Western societies has become more dominant in times of crisis, emergencies, and uncertainties. A small but important group of individuals or organizations formulates CTs.

Their main objective is to secretly develop and promote content for an individual benefit that is against the common good. This misinformation significantly affects social and political events.

As expected, several CTs have emerged during the COVID-19 pandemic. Although CTs were initiated since the first news about the pandemic, their number rose steeply after the World Health Organisation (WHO) declared the global SARS-CoV-2 outbreak a pandemic.

Governments worldwide implemented national lockdowns to prevent further spread of SARS-CoV-2. During lockdowns, the social media use increased substantially. The major vectors for disseminating COVID-19-related CTs are Twitter, YouTube, and Facebook. These platforms generated an infodemic that raised mass suspicions about COVID-19 events.

The rapid spread of the infodemic has significant consequences as it can influence peoples adherence to COVID-19 preventive measures, such as wearing facemasks, conducting social gatherings, and vaccination. Historically, general beliefs in CTs have greatly hindered mass immunization. Likewise, COVID-19-related CTs have increased the tendency to resist vaccination.

Previous studies have also indicated that CTs are developed and spread due to political and psychological agendas. Conspiratorial thinking and social disadvantages, including ethnic minorities, are linked to CT development.

Psychological factors (e.g., different personality traits, emotions, us versus them worldviews, biases, intuitive and paranoid style of thinking), trust in science, education, political orientation, and religiosity also influence CT. Understanding how CTs related to COVID-19 have affected different countries worldwide is imperative.

The current study explored how education, political orientation, trust in scientists, and religiosity influence peoples support for CT.

This study analyzed data from the latest 10th European Social Survey (ESS10) round. The primary data collection method of ESS10 is associated with a face-to-face standardized survey questionnaire. The most recent ESS10 data, published in May 2023, includes information on 26 European countries.

55,555 interviews were conducted with individuals above 15 years of age, irrespective of their citizenship, nationality, language, or legal status.

Although descriptive analyses were performed at the beginning by comparing 26 countries, later multilevel and by-country regressions were conducted to determine the contribution of each predictor. This study observed that CTs have spread in many Western democracies and induced protest movements against the policy measures implemented to contain COVID-19.

Consistent with previous studies, education was an essential covariate of belief in COVID-19-related CTs in Europe. Previous studies have indicated that People with higher education are better trained in logical and analytical thinking. These people are aware of counterarguments, which makes them resistant to believing CTs.

People with higher education were more suspicious about the idea that complex problems have simple solutions and are more skeptical towards CTs. However, this study revealed that the correlation between educational level and belief in CTs was not fixed among all individuals.

A positive correlation between religiosity and CTs was found. People who claim to be religious are skeptical about science and are more inclined towards conservatism, and traditionalism supports CTs more frequently.

Apocalyptic beliefs can drive support for CTs. Quasireligious elements, including esotericism, prophecy, and millennialism, indulge in CTs. A dogmatic religious belief, i.e., fundamentalism, significantly impacts CT.

A lower trust in scientists was strongly linked with the tendency to endorse CTs. A rejection or distrust in science and suspicious behavior towards scientists was strongly associated with higher susceptibility to COVID-19-related misinformation.

In contrast, a higher confidence in scientists was linked with a greater adherence to policies generated to contain the pandemic. For instance, people with higher trust in science are less likely to believe CTs that claimed COVID-19 vaccines to be unsafe and less effective.

Political extremism has been strongly associated with dichotomous, i.e., black-and-white observations. For instance, political extremism has a higher tendency to classify events as good or evil.

This study highlighted that CTs can undermine trust in public health institutions and policies developed and implemented to contain the pandemic. Unlike education, trust in scientists, religiosity, and political orientation moderately influence peoples CT beliefs.

It was recommended to develop policies tailored to different demographic groups and engage them with effective communication strategies to address CTs and their evolving nature.

See the article here:

From education to politics: a pan-European analysis of COVID-19 ... - News-Medical.Net

Isolation no longer required for those positive with COVID-19 – The Hofstra Chronicle

October 29, 2023

October 28, 2023 Ava Dela Pena -- SPECIAL TO THE CHRONICLE

Hofstra University issues news measures for COVID-19 protocols. // Photo Courtesy of Engin Akyhurt

Despite rising COVID-19 rates, Hofstra University has made major changes to its COVID-19 policies regarding isolation.

On Sept. 19, students received an email from Student Health Services (SHS) outlining updated COVID-19 policies. These policies no longer require infected students to isolate in designated COVID-19 housing. Instead, students are expected to isolate in their dorms or homes.

The email advised students to report positive COVID-19 tests on their Medicat portal. Should a student test positive for COVID-19, SHS states that isolation should begin a minimum of 5 full days after you began feeling sick. According to the email, students can resume normal activity while wearing a mask for five days following isolation as long as they are fever-free for 24 hours on the fifth day.

As we cannot verify home or self-testing, images or reports of these tests do not need to be submitted, the email said. Additionally, it is no longer a requirement to report positive diagnoses to faculty.

Micaela Delgado, a sophomore music business major, had a different experience after testing positive for COVID-19. Delgado tested positive on Sept. 10 after using an at-home test, as she expressed difficulty obtaining a test from SHS.

SHS did not instruct me whatsoever on what I should do about having COVID-19, Delgado said.

Expressing concern about her roommates safety, she asked SHS if there were any vacant dorms for her to use while she was positive for the disease.

They said to stay put and hopefully I wont spread it, Delgado said.

According to Beth McGuire, the executive director of campus living, Nassau Hall is no longer used for COVID-19 housing. As to whether it will be used for that purpose in the future, that would be determined by our colleagues in student health and the university administration, in consultation with medical experts, McGuire said.

Delgado also said that SHS advised her to continue going to public places, such as the student center, for meals. They advised her to try to limit her contact with other students.

As for classes, Delgado was advised to go to classes if she felt comfortable. SHS advised her that she just had to wear a mask.

SHS also recommended Delgado to social distance in her dorm. However, Rob Stahl, the executive director of Student Health Services, wrote in a statement that there is no university requirement, but we expect students to take responsibility and isolate.

Conversely, sophomore Ella Bandelin recounted that in the spring 2023 semester, she was required to move to a dorm in Nassau Hall after she tested positive. She recalls being housed in isolation for at least five days before she was allowed to return to her dorm in the Netherlands. Last semester, Nassau Hall was reserved for COVID-19 housing.

They asked about my roommates and if they got [COVID-19], Bandelin said. I had to fill out a form and tell them who I was in contact with so [SHS] could contact them.

Those who were in close proximity with her were contacted by SHS and required to take a COVID-19 test. When they tested positive, they were also required to isolate themselves in Nassau Hall. There, the students were provided with meals and bedding during their stay.

The first significant change in COVID-19 policy was made as early as March 27, when President Susan Poser announced that the schools policy on COVID-19 vaccination would be changing.

Effective immediately, the university will not require Hofstra University students, faculty or staff to be vaccinated against COVID-19, Poser said. Although we strongly encourage all members of our community to stay up to date on vaccines, COVID-19 numbers remain low, with health experts predicting a continued decline.

According to the Centers for Disease Control and Prevention, new COVID-19 hospitalizations in New York initially began decreasing in January but have increased since mid-July.

Continued here:

Isolation no longer required for those positive with COVID-19 - The Hofstra Chronicle

Prevalence and predictors of perceived COVID-19 stigma within a … – BMC Public Health

October 29, 2023

Bagcchi S. Stigma during the COVID-19 pandemic. Lancet Infect Dis. 2020;20(7):782.

Article CAS PubMed PubMed Central Google Scholar

Singh S, Bhutani S, Fatima H. Surviving the stigma: lessons learnt for the prevention of COVID-19 stigma and its mental health impact. Mental Health and Social Inclusion. 2020;24(3):1459.

Article Google Scholar

Adom D, Mensah JA, Osei M. The psychological distress and mental health disorders from COVID-19 stigmatization in Ghana. Social Sci Humanit Open. 2021;4(1):100186.

Google Scholar

Fu L, Wang B, Chan PSF, Luo D, Zheng W, Ju N, et al. Associations between COVID-19 related stigma and sleep quality among COVID-19 survivors six months after hospital discharge. Sleep Med. 2022;91:27381.

Article PubMed Google Scholar

Muhidin S, Vizheh M, Moghadam ZB, Anticipating. COVID-19-related stigma in survivors and health-care workers: lessons from previous infectious Diseases outbreaks - an integrative literature review. Psychiatry Clin Neurosci. 2020;74(11):6178.

Article CAS PubMed Google Scholar

Goffman E. Stigma: notes on the management of spoiled identity. New York: Prentice Hall, Inc. Publication; 1963.

Google Scholar

Link B, Phelan J. Conceptualizing stigma. Ann Rev Sociol. 2001;27:36385.

Article Google Scholar

Gutierrez AM, Schneider SC, Islam R, Robinson JO, Hsu RL, Canfield I, et al. Experiences of stigma in the United States during the COVID-19 pandemic. Stigma and Health; 2022. (Advance online publication).

Choi S. People look at me like I AM the virus: fear, stigma, and discrimination during the COVID-19 pandemic. Qualitative Social Work. 2020;20(12):2339.

Google Scholar

Ren SY, Gao RD, Chen YL. Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus Disease 2019 epidemic. World J Clin Cases. 2020;8(4):6527.

Article PubMed PubMed Central Google Scholar

Yuan Y, Zhao Y, Zhang Q, Zhang L, Cheung T, Jackson T, et al. COVID-19-related stigma and its sociodemographic correlates: a comparative study. Globalization and Health. 2021;17(1):54.

Article PubMed PubMed Central Google Scholar

Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013;103(5):81321.

Article PubMed PubMed Central Google Scholar

Villa S, Jaramillo E, Mangioni D, Bandera A, Gori A, Raviglione MC. Stigma at the time of the COVID-19 pandemic. Clin Microbiol Infect. 2020;26(11):14502.

Article CAS PubMed PubMed Central Google Scholar

Yuan K, Huang X, Yan W, Zhang Y, Gong Y, Su S, et al. A systematic review and meta-analysis on the prevalence of stigma in infectious Diseases, including COVID-19: a call to action. Mol Psychiatry. 2022;27(1):1933.

Article CAS PubMed Google Scholar

Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453.

Article PubMed PubMed Central Google Scholar

Wolitski RJ, Pals SL, Kidder DP, Courtenay-Quirk C, Holtgrave DR. The effects of HIV stigma on health, disclosure of HIV status, and risk behavior of homeless and unstably housed persons living with HIV. AIDS Behav. 2009;13(6):122232.

Article PubMed Google Scholar

Reif S, Wilson E, McAllaster C, Pence B. The relationship of HIV-related stigma and health care outcomes in the US Deep South. AIDS Behav. 2019;23(3):24250.

Article PubMed Google Scholar

Person B, Sy F, Holton K, Govert B, Liang A. National Center for Inectious Diseases. Fear and stigma: the epidemic within the SARS outbreak. Emerg Infect Dis. 2004;10(2):35863.

Article PubMed PubMed Central Google Scholar

Centers for Disease Control and Prevention. Addressing stigma. 2017. Available from: https://emergency.cdc.gov/cerc/cerccorner/article_123016.asp. Accesed 1 May 2023.

Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):21427.

Article PubMed Google Scholar

Schroeder J, DeLong S, Heintz S, Nadimpalli M, Yourkavitch J, Aiello AE. Ebola as an instrument of discrimination. Robert Wood Johson Foundation Cultural of Health. 2014. Available from: http://www.rwjf.org/en/blogs/human-capital-blog/2014/11/ebola_as_an_instrume.html. Accesed 1 Mar 2023.

Overholt L, Wohl DA, Fischer WA 2nd, Westreich D, Tozay S, Reeves E, et al. Stigma and Ebola survivorship in Liberia: results from a longitudinal cohort study. PLoS ONE. 2018;13(11):e0206595.

Article PubMed PubMed Central Google Scholar

Karamouzian M, Hategekimana C. Ebola treatment and prevention are not the only battles: understanding Ebola-related fear and stigma. Int J Health Policy Manag. 2015;4(1):556.

Article PubMed Google Scholar

Cnat JM, Felix N, Blais-Rochette C, Rousseau C, Bukaka J, Derivois D, et al. Prevalence of mental health problems in populations affected by the Ebola virus Disease: a systematic review and meta-analysis. Psychiatry Res. 2020;289:113033.

Article PubMed Google Scholar

Alchawa M, Naja S, Ali K, Kehyayan V, Haddad PM, Bougmiza I. COVID-19 perceived stigma among survivors: a cross-sectional study of prevalence and predictors. Eur J Psychiatry. 2022;37(1):2435.

Article PubMed PubMed Central Google Scholar

Liu Y, Finch BK, Brenneke SG, Thomas K, Le PD. Perceived discrimination and mental distress amid the COVID-19 pandemic: evidence from the understanding America study. Am J Prev Med. 2020;59(4):48192.

Article PubMed PubMed Central Google Scholar

Michigan Department of Health and Human Services. Regional trauma networks. 2022. Available from: https://www.michigan.gov/mdhhs/doing-business/trauma/regional Accessed 1 May 2023.

Deville J, Sarndal C. Calibration estimators in survey sampling. J Am Stat Assoc. 1992;87(418):37682.

Article Google Scholar

The American Association for Public Opinion Research. Standard definitions: Final dispositions of case codes and outcome rates for surveys. 2016. Available from: https://aapor.org/standards-and-ethics/standard-definitions/ Accessed 1 May 2023.

Cox BG. The weighted sequential hot deck imputation procedure. ASA Proc Section on Survey Res Methods. 1980:7216.

Mayer B. Hot deck propensity score imputation for missing values. Science Journal of Medicine and Clinical Trials. 2013. Available from: https://www.sjpub.org/sjmct/sjmct-248.pdf Accessed 10 Nov 2023.

Williams DR, Yan Y, Jackson JS, Anderson NB. Racial differences in physical and mental health: Socio-economic status, stress and discrimination. J Health Psychol. 1997;2(3):33551.

Article CAS PubMed Google Scholar

Petrosyan STN, CS, Angrisani M, Khobragade P, Banerjee J, Agarwal A, Bloom D, Schaner S, Dey AB, Lee J. Real Time Insights (RTI): COVID-India: rounds 19, 20202022. [data collection]. Version A. 2022. Available from: https://lasi-dad.org/covid Accessed 1 Dec 2022.

Le PD, Misra S, Hagen D, Wang SM, Li T, Brenneke SG, et al. Coronavirus Disease (COVID-19) related discrimination and mental health in five U.S. Southern cities. Stigma and Health. 2022;8(1):1337.

Article Google Scholar

Lin B, Zhong G, Liang Z, Huang J, Wang X, Lin Y. Perceived-stigma level of COVID-19 patients in China in the early stage of the epidemic: a cross-sectional research. PLoS ONE. 2021;16(10):e0258042.

Article CAS PubMed PubMed Central Google Scholar

Gopichandran V, Subramaniam S. A qualitative inquiry into stigma among patients with Covid-19 in Chennai, India. Indian J Med Ethics. 2021;6(3):121.

Article Google Scholar

Nydegger LA, Hill MJ. Examining COVID-19 and HIV: the impact of intersectional stigma on short- and long-term health outcomes among African americans. Int Social Work. 2020;63(5):6559.

Article Google Scholar

Wakeel F, Njoku A. Application of the weathering framework: intersection of racism, stigma, and COVID-19 as a stressful life event among African americans. Healthcare. 2021;9(2).

Stangl AL, Earnshaw VA, Logie CH, van Brakel W, Simbayi C, Barr L. The health stigma and discrimination framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17(1):31.

Article PubMed PubMed Central Google Scholar

Jackson-Best F, Edwards N. Stigma and intersectionality: a systematic review of systematic reviews across HIV/AIDS, mental Illness, and physical disability. BMC Public Health. 2018;18(1):919.

Article PubMed PubMed Central Google Scholar

Turan JM, Elafros MA, Logie CH, Banik S, Turan B, Crockett KB, et al. Challenges and opportunities in examining and addressing intersectional stigma and health. BMC Med. 2019;17(1):7.

Article PubMed PubMed Central Google Scholar

Tsai AC, Bangsberg DR, Bwana M, Haberer JE, Frongillo EA, Muzoora C, et al. How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda. AIDS Behav. 2013;17(8):272531.

Article PubMed PubMed Central Google Scholar

Swendeman D, Rotheram-Borus MJ, Comulada S, Weiss R, Ramos ME. Predictors of HIV-related stigma among young people living with HIV. Health Psychol. 2006;25:5019.

Article PubMed PubMed Central Google Scholar

Schabert J, Browne JL, Mosely K, Speight J. Social stigma in diabetes. The Patient: Patient-Centered Outcomes Research. 2013;6(1):110.

Conrad P, Barker KK. The social construction of Illness: key insights and policy implications. J Health Soc Behav. 2010;51(1suppl):67S79.

Article Google Scholar

Corrigan PW, Rafacz J, Rsch N. Examining a Progressive model of self-stigma and its impact on people with serious mental Illness. Psychiatry Res. 2011;189(3):33943.

Article PubMed PubMed Central Google Scholar

Puhl RM, Heuer CA. Obesity stigma: important considerations for public health. Am J Public Health. 2010;100(6):101928.

Article PubMed PubMed Central Google Scholar

Kwok S, Adam S, Ho JH, Iqbal Z, Turkington P, Razvi S, et al. Obesity: a critical risk factor in the COVID-19 pandemic. Clin Obes. 2020;10(6):e12403.

Article PubMed PubMed Central Google Scholar

Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21(11):e13128.

Article CAS PubMed PubMed Central Google Scholar

Lieberman-Cribbin W, Tuminello S, Flores RM, Taioli E. Disparities in COVID-19 testing and positivity in New York City. Am J Prev Med. 2020;59(3):32632.

Article PubMed PubMed Central Google Scholar

Servick K. Huge hole in COVID-19 testing data makes it harder to study racial disparities. 2020. Scinece. Available from: https://www.science.org/content/article/huge-hole-covid-19-testing-data-makes-it-harder-study-racial-disparities. Accessed 1 Dec 2022.

Earnshaw VA, Brousseau NM, Hill EC, Kalichman SC, Eaton LA, Fox AB. Anticipated stigma, stereotypes, and COVID-19 testing. Stigma and Health. 2020;5:3903.

Article Google Scholar

Wu C, Qian Y, Wilkes R. Anti-asian discrimination and the asian-white mental health gap during COVID-19. Ethnic and Racial Studies. 2021;44(5):81935.

Article Google Scholar

Litam SDA, Oh S. Effects of COVID-19-related racial discrimination on depression and life satisfaction among young, middle, and older Chinese americans. Adultspan J. 2021;20(2):7084.

Article Google Scholar

Oh S, Araez Litam SD, Chang CY. COVID-19 racial discrimination and mental health of Korean americans: role of ethnic identity and coping strategy. Stigma and Health. 2022;7(4):46170.

Article Google Scholar

Read the rest here:

Prevalence and predictors of perceived COVID-19 stigma within a ... - BMC Public Health

SARS-CoV-2 Omicron variant more common, tied to more severe … – University of Minnesota Twin Cities

October 29, 2023

SARS-CoV-2 Omicron infections were more common and linked to more severe outcomes than influenza and respiratory syncytial virus (RSV) in emergency department (ED) patients in Sweden, especially among those unvaccinated against COVID-19.

The findings were published yesterday in Clinical Infectious Diseases.

Karolinska Institutet researchers assessed rates of 30-day all-cause death, hospitalization, and intensive care unit (ICU) admission of adults seen in six EDs in Stockholm County for Omicron, flu, or RSV infection in 2021-2022 and 2015-2019. Of 6,385 patients in 2021-2022, 76% were infected with Omicron, 17% had flu, and 7% had RSV.

In total, 22.1% of Omicron patients were unvaccinated against COVID-19 before their ED visit, while 75% had received at least two doses.

Thirty-day death rates were 7.9% in the Omicron group, 2.5% in flu patients, and 6.0% in the RSV group. Omicron patients' adjusted death odds ratio (OR) was 2.36 compared with flu and 1.42 compared with RSV. Stronger links were seen in unvaccinated Omicron patients relative to flu (OR, 5.51) and RSV (OR, 3.29).

Death rates at 30 days were 15% among Omicron patients aged 75 years or older, compared with 8% in the 2021-2022 flu group, 12% in the 2021-2022 RSV cohort, 7% among 5,709 prepandemic flu patients, and 9% among 955 prepandemic RSV patients. Among Omicron patients who received at least two COVID-19 vaccine doses, the OR for death was 2.00 compared with flu and 1.20 compared with RSV.

This underscores the need for public health strategies for managing and mitigating the impact of Omicron and other viral respiratory infections, with continued assessments of their comparative severity.

Ninety-day mortality was 11% among Omicron patients, 3.7% in 2021-2022 flu patients, 8.7% in 2021-2022 RSV patients, 5.1% in the prepandemic flu group, and 9.6% in prepandemic RSV patients.

In 2021-2022, 30-day mortality was 2.6% for influenza A patients; none of the 17 influenza B patients died. From 2015 to 2019, 30-day mortality was 3.2% in influenza A patients and 3.8% in influenza B patients.

"This underscores the need for public health strategies for managing and mitigating the impact of Omicron and other viral respiratory infections, with continued assessments of their comparative severity," the authors wrote.

See the rest here:

SARS-CoV-2 Omicron variant more common, tied to more severe ... - University of Minnesota Twin Cities

COVID and Flu Vaccine Risk; Medicare Advantage Fraud; $1.4B … – Medpage Today

October 29, 2023

Note that some links may require registration or subscription.

Adults 85 and older who received COVID and flu vaccines at the same time appeared to have a very small higher risk of stroke. (CNN)

Only 7% of U.S. adults and 2% of kids received the new COVID-19 vaccine as of two weeks ago, according to the CDC. (AP)

An mRNA-based combination flu-COVID vaccine generated a strong immune response in a mid-stage trial of adults, developers Pfizer and BioNTech said.

A former executive at a South Florida Medicare Advantage organization was charged for her alleged role in a roughly $53 million fraud scheme, the Department of Justice said.

Exela Pharma Sciences issued a nationwide recall of some of its sodium bicarbonate, midazolam, and cysteine hydrochloride injections.

Here are warning signs that America's healthcare workforce is burned out. (Axios)

And here's how burnout is playing out among large retail pharmacists, too. (USA Today)

Republicans delayed more than $1 billion in funding for the PEPFAR HIV program. (The Washington Post)

An audit of the Maryland Heath Departments found $1.4 billion in unaccounted-for funds that the state received during the pandemic. (The Washington Post)

The only medical school on a Native American reservation is preparing students to serve in rural and tribal areas. (CBS News)

While global vaccine coverage for kids improved in past years, they're not back to pre-pandemic levels. (MMWR)

What would happen to developing nations if COVID-related patents were suspended? (The Hill)

Lawmakers are looking for ways to speed up the FDA approval process for new rare disease treatments. (Endpoints News)

Two workers at a Japanese nuclear power plant were hospitalized after being sprayed with liquid laced with radioactive materials. (AP)

Children and adolescents who received mental health counseling or therapy increased from 10% in 2019 to 13.8% in 2022, CDC data showed.

Twice as many parents of kids ages 9 to 15 reported concerns about internet addiction than substance addiction. (JAMA Network Open)

A woman filed a lawsuit against her ob/gyn claiming he secretly used his own sperm to impregnate her during fertility treatments. (The Seattle Times)

Healthcare professionals at D.C.'s Unity Health Care are trying to unionize. (DCist)

Savannah renamed one of its town squares after the first Black Civil War nurse. (The Atlanta Journal-Constitution)

Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, shes worked at the company since 2015.

Link:

COVID and Flu Vaccine Risk; Medicare Advantage Fraud; $1.4B ... - Medpage Today

COVID-19 Vaccines Have Not Been Shown to Alter DNA, Cause Cancer – FactCheck.org

October 27, 2023

SciCheck Digest

Small amounts of DNAfrom the manufacturing process may remain in the mRNA COVID-19 vaccines. Purification andquality control steps ensure any leftover DNA is present within regulatory limits. There isnt reason to think that this residual DNA would alter a persons DNA or cause cancer, contrary to claims made online.

How do we know vaccines are safe?

No vaccine or medical product is 100% safe, but the safety of vaccines is ensured via rigorous testing in clinical trials prior to authorization or approval, followed by continued safety monitoring once the vaccine is rolled out to the public to detect potential rare side effects. In addition, the Food and Drug Administration inspects vaccine production facilities and reviews manufacturing protocols to make sure vaccine doses are of high-quality and free of contaminants.

One key vaccine safety surveillance program is the Vaccine Adverse Event Reporting System, or VAERS, which is an early warning system run by the Centers for Disease Control and Prevention and FDA. As its website explains, VAERS is not designed to detect if a vaccine caused an adverse event, but it can identify unusual or unexpected patterns of reporting that might indicate possible safety problems requiring a closer look.

Anyone can submit a report to VAERS for any health problem that occurs after an immunization. There is no screening or vetting of the report and no attempt to determine if the vaccine was responsible for the problem. The information is still valuable because its a way of being quickly alerted to a potential safety issue with a vaccine, which can then be followed-up by government scientists.

Another monitoring system is the CDCs Vaccine Safety Datalink, which uses electronic health data from nine health care organizations in the U.S. to identify adverse events related to vaccination in near real time.

In the case of the COVID-19 vaccines, randomized controlled trials involving tens of thousands of people, which were reviewed by multiple groups of experts, revealed no serious safety issues and showed that the benefits outweigh the risks.

The CDC and FDA vaccine safety monitoring systems, which were expanded for the COVID-19 vaccines and also include a new smartphone-based reporting tool called v-safe, have subsequently identified only a few, very rare adverse events.

For more, see How safe are the vaccines?

Link to this

The COVID-19 vaccines made by Pfizer/BioNTech and Moderna areproducedwith help from DNA templates, which include instructions for making the mRNA that encodes the spike protein. Manufacturers take steps topurifythe final vaccine components, cutting up and removing the DNA, although there could be a very small amount of DNA left.

Past research and mechanistic logic indicate that any DNA remaining after these purification and quality control steps is likely inconsequential. However, in recent months unsubstantiated theories have spreadonlinethatDNA remaining inmRNAvaccines couldintegrate into a persons ownDNA and cause cancer, or even that the vaccines are already causing cancer.

A spokesperson from the U.S. Food and Drug Administration told us in an email that no safety concerns related to residual DNA have been identified. The spokesperson added that with regard to the mRNA vaccines, while concerns have been raised previously as theoretical issues, available scientific evidence supports the conclusion that the minute amounts of residual DNA do not cause cancer or changes to a persons genetic code.

A spokesperson for the European Medicines Agency which helps regulate medical products in the European Union told us via email that the agency can confirm that we have not seen any reliable evidence of residual DNA exceeding approved/safe levels for the Pfizer/BioNTech or Moderna COVID-19 vaccines. Nor is the EMA aware of scientific evidence showing that the very small amounts of residual DNA that may be present in vaccine batches could integrate into the DNA of vaccinated individuals, the spokesperson continued.

Various experts also told us that it is unlikely that residual DNA in the vaccines could integrate into DNA or cause cancer, even in theory. And as we have previouslywritten, there isntevidenceto date that the vaccines cause cancer or have led to an increase in cancer.

Marc Veldhoen, an immunologist at the Instituto de Medicina Molecular Joo Lobo Antunes in Portugal, told us via email that residual DNA would be expected, but he refuted the idea that it could cause cancer. Yes, there would be some fragments, but within the limit this is allowed and without any clinical consequence, he said.

This family of claims was originally inspired by a preprint posted in April, which said there was DNA contamination that exceeds the EMA and FDA regulatory limits in Moderna and Pfizer/BioNTech vaccine vials sent anonymously to the authors in the mail without cold packs. This led to other reports of DNA in mRNA vaccine vials, including a second preprint that analyzed largely expired vaccine vials obtained at pharmacies in Canada.None of this work has been published in peer-reviewed journals, and many elements of it have been criticized.

We reached out to Kevin McKernan, an author on both preprints, to better understand his views. Rather than replying to our email, he posted a screenshot of it on X, formerly known as Twitter, and included responses there. McKernan, who has an undergraduate degree in biology, is the founder of Medicinal Genomics, a company that markets test kits and genomics-related services to the cannabis, hemp and mushroom industries.

Some of the alleged concern has focused on the possibility, raised in the original preprint, that some of the residual DNA in the Pfizer/BioNTech vaccine is from a monkey virus called SV40. The EMA confirmed to us that the plasmid, or DNA template, used to make the Pfizer/BioNTech vaccine contains some short sections of DNA from this virus. A Pfizer spokesperson also told us via email that specific, non-infectious parts of the SV40 sequence, which are commonly used in the pharmaceutical industry are present in starting material used by Pfizer and BioNTech.

But none of the sequences identified in the preprint are known to cause cancer, contrary to recent social mediapoststhatsay SV40, a cancer causing sequence was put in the Covid Vaccine.

Experts say there isnt reason to think that any small pieces of leftover DNA, including SV40 DNA, in the vaccines would be harmful.

It is very unlikely that any residual DNA would integrate into a persons genome and if it did it would be even much less likely to cause cancer, Barry Milavetz, a molecular biologist who studies SV40 at the University of North Dakota, told us in an email.

Reports of residual DNA in the mRNA COVID-19 vaccines and its purported dangers spread further after a Sept. 12 South Carolina Senate committeelistening session. One speaker, molecular biologist and cancer geneticistPhillip Buckhaultsfrom the University of South Carolina, sharedhis ownfindings that DNA pieces were present in leftover vaccine in the bottom of used Pfizer/BioNTech vials.

In hispresentation, which was shared widely online, he said that DNA can and likely will integrate into the genomes of peoples cells, and he shared concerns about various potential health impacts, including cancer. As weve said, other experts and regulatory agencies disagree that residual DNA is likely to integrate into a persons own DNA.

It was surprising to me to see any DNA in this product, and I am a bit concerned about the theoretical possibility of genome modification, Buckhaults told us in an email. I want the scientific community to help find out if this is a real hazard or not a problem.

He also said that he did not intend for his comments to be widely circulated in the public and compromising peoples confidence in vaccines.

Another widely posted clip from the listening session was of Janci Lindsay, who runs a toxicology consulting firm and has a history ofsharingincorrectinformationabout vaccines and COVID-19. She also spoke about unsubstantiated cancer risks andtoldthe lawmakers that she believes the SV40 DNA sequences were included in the vaccines with nefarious intent. The idea that the presence of these sequences is nefarious is a conspiracy theory with no basis in reality.

Lindsay goes on to reference hydroxychloroquine and ivermectin, falsely concluding, We never needed these vaccines. We had treatments that worked. This is incorrect. The COVID-19 vaccines saved many lives, and randomized controlled trials have shown that hydroxychloroquine and ivermectin do not help people recover from COVID-19.

FactCheck.org obtained a copy of an Oct. 16 letter sent to the Senate committee by Pfizer. In the letter, Pfizer disagrees with comments made during the session, saying that statements are incorrect that the vaccine contains plasmid DNA that could potentially impact a persons DNA and be a theoretical cancer risk. The letter continues, There is no evidence to support these claims and they provide the risk of being misconstrued by either Committee members and/or the public at large.

The letter also states that no signs of DNA mutation or COVID-19 vaccine-induced cancer have been reported to date related to the Pfizer/BioNTech COVID-19 vaccine.

Research into residual DNA in vaccinesdates back decades. Anti-vaccine fear-mongering aboutresidual DNAor other substances invaccinesis also not a new phenomenon.

Many currently available vaccines are made using cells. Some vaccines, such as the one againstchickenpox, rely on weakened virus that is grown in cells. For other vaccines, such as forhepatitis A, viruses are grown in cell culture and then inactivated. Cells also can be used to produce protein-based vaccines. One example is the COVID-19 vaccine fromNovavax, which is grown in moth cells.

In all of these cases, the active ingredients for the vaccines are purified, but thevaccinescan stillcontainsmallamountsofresidual DNAfrom thecellsused to make them. The FDA and other regulatory agencies have offeredguidanceon limiting the quantity and size of residual DNA left over from cells used to make vaccines.

The limits are based on thetheoretical concernthat residual DNA specifically from mammalian cell lines could cause cancer or a viral infection, particularly if there were a cancer-causing gene or certain viral DNA present in the cell line. But Dr. Paul Offit, director of the Vaccine Education Center at Childrens Hospital of Philadelphia, told us that regulatory limits on residual DNA in vaccines are set conservatively.

Pfizers letter to the South Carolina Senate committee refers to a quality control process that ensures that residual DNA levels in its mRNA vaccine for COVID-19 are within regulatory limits.

The validated method for assessment of residual DNA has shown that the Pfizer-BioNTech COVID-19 vaccine meets the requirements of the World Health Organization (WHO) and the FDA for biological products, the letter states. Vaccine batches are only certified and released if the criteria, during quality control testing, are met using the validated and approved method.

The EMA spokesperson added that in the European Union, these results must be checked by an independent laboratory. As a result, we are confident that the DNA levels in the vaccine are consistently below the approved/safe level, the spokesperson said.

A spokesperson from the Therapeutic Goods Administration, which regulates medical products in Australia, told us that the agency has been monitoring batches of Moderna and Pfizer/BioNTech mRNA COVID-19 vaccines. This includes independent testing performed by the TGA laboratories to confirm that residual DNA impurity levels arebelow the acceptable limit, the spokesperson told us in an email. To date all batches of COVID-19 vaccines supplied in Australia have met all quality specifications.

Research on experimental DNA vaccines, which contain DNA as their active ingredient, also supports the idea that DNA in vaccines is unlikely to integrate into a persons DNA. Stephen M. Kaminsky, a professor of research in genetic medicine at Weill Cornell Medical College, told us via email that there is little concern of integration from DNA vaccines that are delivered in much greater quantities than any residual DNA that might be found in one of the mRNA vaccines for COVID-19.

Since amounts of DNA vaccines in the milligram range have been approved for clinical evaluation, it is difficult to imagine that the smaller quantities of residual cell-substrate DNA present in viral vaccines would pose a significant risk due to integration, FDA scientists also concluded in onepaper.

The FDA scientists went on to state that they consider the primary cancer-related concern with DNA in vaccines to be the introduction of an activated version of a cancer-causing gene to a cell not just any DNA integrating into the genome at the wrong place.

Offit added that we are constantly exposed to DNA, including in the food we eat and from viruses that dont cause cancer.

Experts told us that theories for how residual DNA would cause cancer rely on an entire series of events, many of them unlikely.

As weve discussed above, changing a persons DNA is not easy. The residual DNA would first need to get into a cell. This could happen if the DNA was inside one of the fatty bubbles called lipid nanoparticles used to package the mRNA in the vaccines, Veldhoen, the immunologist in Portugal, said. But even if this happened, the DNA would only end up in the cytoplasm, the region of a cell outside the nucleus.

Next, any residual DNA that made it into a cell would need to get access to a persons DNA in the nucleus and insert itself. In general, a cell needs to be in the process of dividing for foreign DNA to integrate into the cells own DNA.

The mRNA vaccines are injected into the muscles, where the bulk of the vaccine remains. Muscle cells do not divide rapidly and have lots of cytoplasm compared to the size of their nuclei, Milavetz, the molecular biologist at the University of North Dakota, said. This means that it is very unlikely that any residual DNA from a vaccine introduced to the cytoplasm of a cell will make it into the nucleus and insert itself into the DNA there in the first place, he added.

Even if it enters the nucleus, which it probably cant, it would still have to be integrated into DNA, which requires an integrase, which it also doesnt have, Offit said. An integrase is an enzyme some viruses use to insert themselves into cellular DNA.

In the event that some residual DNA did manage to insert into a persons DNA, it would need to be exactly the wrong kind of DNA, land in exactly the wrong place or a combination of the two.

And then, if this entire sequence of events occurred in one of a persons trillions of cells, the cell would need to avoid destruction by the immune system, divide and give rise to other cells, which would need to continue along the path toward becoming cancerous.

In reality, the immune system can detect when cells take up foreign DNA or mRNA, Veldhoen said. In the end, cells that had taken up residual DNA would not survive, he said, and the DNA bits would be broken down, its individual parts recycled.

As weve said, social media posts misleadingly refer to the presence of SV40, a cancer causing sequence. This brings to mind past concerns, which were not borne out, that contamination of polio vaccines with the entire SV40 virus could cause cancer. Researchers discovered in 1960 that monkey kidney cells that had been used to produce some polio vaccines were contaminated with SV40, which was found to cause cancer in rodents. But the virus has not been shown to cause cancer in humans, and the contamination did not ultimately lead to more cancer in children who received the contaminated vaccines compared with those who didnt.

The small amount of SV40 DNA in the DNA template for the Pfizer/BioNTech vaccine does not encode the entire virus. SV40 is a naturally occurring virus and the virus itself is not included in either starting materials, plasmid DNA, or in the final product of the Pfizer-BioNTech COVID-19 vaccine, the Pfizer spokesperson said.

McKernans original preprint did not indicate the presence of the whole virus or any DNA encoding viral proteins, but rather highlighted regulatory DNA. Regulatory DNA, including a type of sequence called a promoter, helps control which genes in a cell are turned on.

Milavetz said that the portion of SV40 shown to have the potential for causing cancer in the lab encoding a protein called T-antigen is not among the sequences McKernan identified in the vaccine.

It is unclear why the Pfizer/BioNTech DNA template would include SV40 regulatory DNA. The EMA told us that the sequence is not directly relevant for producing copies of the DNA template or for producing mRNA for the vaccine, so it is considered to be a non-functional part of the structure of the source plasmid.

McKernan has suggested that a piece of SV40 regulatory DNA could cause cancer by integrating into a persons DNA and turning on a cancer-causing gene. In response to criticisms that its difficult for DNA to get into the nucleus, McKernan points toresearchshowing a role for part of that sequence in helping to bring DNA into the cell nucleus.

But its hardly clear that any nuclear entry mechanism would be at play in human cells exposed to residual DNA fragments. And as we have previously explained, there are multiple reasons why residual DNA is unlikely to integrate into a persons DNA.

Fragments of the SV40 sequence may only be present as residual impurities at very low levels that are routinely controlled, the EMA spokesperson said. There is no scientific evidence that any of these SV40 fragments can act as insertional mutagens, the spokesperson said, meaning there is no evidence the fragments would integrate into a persons DNA.

Buckhaults, who also found SV40 regulatory DNA in Pfizer/BioNTech vaccine vials, told us thebits of SV40 DNA arent any more dangerous than all the other bits of DNA he found in the vaccine vials.

Milavetz pointed out the improbability of the SV40 regulatory sequence causing cancer, even if it did somehow integrate into a persons DNA.

He said that any residual DNA present would be unlikely to contain only the SV40 sequence needed to turn on a gene. There would likely be extra chunks of DNA that would prevent it from functioning.

For this to be a viable problem only critical portions of the promoter would have to be introduced into the regulatory region of only a very small subset of genes in a human in a very specific way, he said. In my opinion there are too many things that would have to occur perfectly for the promoter to be integrated into one of these critical human genes.

Various posts also reference a change in the DNA template used to produce the Pfizer/BioNTech vaccine between the clinical trials and the rollout of the vaccine to the general public. To make the vaccine supply that was primarily used in the clinical trials, manufacturers produced copies of the DNA template using a process called PCR, in which DNA is amplified in a lab without the help of biological organisms. To help scale up production, manufacturers enlisted bacteria to make many copies of a plasmid, a circular piece of DNA. The bacteria divide rapidly and can make large quantities of DNA.

Based on this process change, social media posts have said that the Pfizer covid vaccine approved the for emergency use was not the same one used on the public! or posted the BREAKING news that Pfizers COVID vaccine that was approved for emergency use was not the same one they injected into billions of arms.

To be clear, the fact there was a process change has long been publicly available information. It is mentioned in the Pfizer clinical trial protocol, the emergency use authorization from the FDA and an EMA public assessment report first published in December 2020. The EMA spokesperson confirmed thatvaccine batchesproduced by both processes were tested in clinical studies, adding that the manufacturer provided test results and other information to show the comparability of the product resulting from both processes.This assessmentof comparability confirmed there was no meaningful difference in the quality of material from process 1 and process 2 that could impact the safety and/or efficacy of the vaccine, the EMA spokesperson said.

Editors note: SciChecks articles providing accurate health information and correcting health misinformation are made possible by a grant from the Robert Wood Johnson Foundation. The foundation has no control over FactCheck.orgs editorial decisions, and the views expressed in our articles do not necessarily reflect the views of the foundation.

COVID-19 mRNA Vaccine Production.National Human Genome Research Institute website. Updated 31 Aug 2021.

Naik, Ramachandra, and Peden, Keith. Regulatory Considerations on the Development of mRNA Vaccines.mRNA Vaccines, edited by Dong Yu and Benjamin Petsch, Springer International Publishing, 2022, pp. 187205.

The Florida Standard (@theflstandard). Renowned microbiologist Kevin McKernan discovered shocking levels of potentially cancer-causing contaminants in the mRNA shots. Details at link in bio. Instagram. 1 Jun 2023.

Vesterberg, Jonas. Former MIT Lead Scientist Finds Monkey Virus DNA in COVID Vaccines. The Florida Standard. 1 Jun 2023.

Dr. Simon Goddek (@goddeketal). This new discovery of the presence of green monkey DNA, including tumor-linked viral promoters, in the jabs has this microbiologist and immunologist calling for an immediate halt in the use of mRNA vaccines. All perpetrators must be arrested immediately! X. 12 Jun 2023.

Mercola, Joseph. Monkey Virus DNA Found in COVID-19 Shots. The Epoch Times. Updated 20 Jun 2023.

momma exposing corruption (@free_spirit_momma). #educate #inform. Instagram. 30 Sep 2023.

Think Truth (@think_truth_). They always knew #Repost @ifyindulgeglobal. Instagram. 7 Oct 2023.

Barnett, Rebekah. Scientists Shocked and Alarmed at Whats in the mRNA Shots. The Spectator Australia. 25 Sep 2023.

Johnson, Mandi. IF THERES ONE THING YOU NEED TO WATCH TODAY ITS THIS.. #CanWeTalkAboutIt #RealNotRare . Facebook. 18 Sep 2023.

Tolduso, Mandee. [no text]. Facebook. 21 Sep 2023.

DiedSuddenly (@DiedSuddenly_). Why was SV40, a cancer causing sequence, put in the Covid Vaccine? Because Cancer is the Medical Industrial Complexs #1 money maker. Now, 20 year olds are getting turbo cancer, and those who were once in remission have had their cancer come back 10x worse. It was all intentional. X. 20 Sep 2023.

U.S. Food and Drug Administration spokesperson. Email to FactCheck.org. 5 Oct 2023.

European Medicines Agency spokesperson. Email to FactCheck.org. 23 Oct 2023.

Yandell, Kate. COVID-19 Vaccines Have Not Been Shown to Cause Turbo Cancer. FactCheck.org. 31 Aug 2023.

Yandell, Kate. TikTok Video Mangles American Cancer Society Breast Cancer Estimates. FactCheck.org. 23 June 2023.

Veldhoen, Marc. Emails with FactCheck.org. 11 Oct and 24 Oct 2023.

McKernan, Kevin, et al. Sequencing of Bivalent Moderna and Pfizer Mrna Vaccines Reveals Nanogram to Microgram Quantities of Expression Vector dsDNA Per Dose. OSF Preprints. 10 Apr 2023. Updated 25 Sep 2023.

SC 4 FREEDOM. SC Senate Hearing USC Professor Dr. Phillip Buckhaults. YouTube. 13 Sep 2023.

Speicher, David J. et al. DNA Fragments Detected in Monovalent and Bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 Vaccines from Ontario, Canada: Exploratory Dose Response Relationship with Serious Adverse Events. OSF Preprints. 19 Oct 2023. Updated 20 Oct 2023.

Debunk the Funk With Dr. Wilson. Anti-vaxxers fail again: putting DNA contamination nonsense to rest. YouTube. 25 Oct 2023.

Orac. VAERS and Plasmid DNA Contamination of COVID-19 Vaccines: The Nonsense Continues. Respectful Insolence. 21 Oct 2023.

Milavetz, Barry. Email to FactCheck.org. 5 Oct 2023.

Senate Medical Affairs Pandemic Preparedness Listening Session. South Carolina Legislature website. Accessed 26 Oct 2023.

Cedric Basile Tchinda (@cedricminator). [no text]. Instagram. 5 Oct 2023.

Buckhaults, Phillip. Email to FactCheck.org. 17 Oct 2023.

Settles, Gabrielle. Evidence shows that COVID-19 variants are largely spread among unvaccinated people. PolitiFact. 25 Aug 2021.

Janci Chunn Lindsays Claims That COVID-19 Vaccines Are Unsafe Are Inaccurate and Unsupported by Scientific Evidence. Health Feedback. 23 Aug 2021.

SC 4 FREEDOM. SC Senate Hearing Dr. Janci Lindsay. YouTube. 15 Sep 2023.

Jaramillo, Catalina. mRNA Vaccines Protect Against COVID-19 Mortality, Contrary to Misleading Posts. FactCheck.org. 26 May 2023.

Robertson, Lori. No New Revelation on Hydroxychloroquine and COVID-19. FactCheck.org. 2 Jul 2021.

Ivermectin. NIH COVID-19 Treatment Guidelines. Updated 6 Mar 2023.

Anderson, Annaliesa, Pfizer. Letter to South Carolina Senate Medical Affairs Committee. 16 Oct 2023.

See original here:

COVID-19 Vaccines Have Not Been Shown to Alter DNA, Cause Cancer - FactCheck.org

Page 50«..1020..49505152..6070..»